title: The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.
authors.affiliation: Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland.
authors.forename: Shaza N
authors.initials: SN
authors.lastname: Al-Holou
authors.affiliation: Laboratory of Immunology, National Eye Institute/National Institutes of Health, Bethesda, Maryland.
authors.forename: William R
authors.initials: WR
authors.lastname: Tucker
authors.affiliation: Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland.
authors.forename: Elvira
authors.initials: E
authors.lastname: Agrón
authors.affiliation: The EMMES Corporation, Rockville, Maryland.
authors.forename: Traci E
authors.initials: TE
authors.lastname: Clemons
authors.affiliation: The EMMES Corporation, Rockville, Maryland.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Sperduto
authors.affiliation: Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland.
authors.forename: Frederick L
authors.initials: FL
authors.lastname: Ferris
authors.affiliation: Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland. Electronic address: echew@nei.nih.gov.
authors.forename: Emily Y
authors.initials: EY
authors.lastname: Chew
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002386:Cataract / Q000175:diagnosis* / Q000453:epidemiology*; D002387:Cataract Extraction / Q000706:statistics & numerical data*; D018450:Disease Progression; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D014975:Lutein / Q000627:therapeutic use; D008268:Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D057216:Propensity Score; D016016:Proportional Hazards Models; D011446:Prospective Studies; D014481:United States / Q000453:epidemiology; D065146:Zeaxanthins / Q000627:therapeutic use
chemical_list: D015525:Fatty Acids, Omega-3; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D065146:Zeaxanthins; D014975:Lutein